STOCK TITAN

The Campbell's Company Financials

CPB
Source SEC Filings (10-K/10-Q) Updated Nov 2, 2025 Currency USD FYE August
Export CSV

This page shows The Campbell's Company (CPB) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 18 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Key Financial Metrics

Revenue
$10.3B
YoY+6.4%
5Y CAGR+3.4%
10Y CAGR+2.4%

The Campbell's Company generated $10.3B in revenue in fiscal year 2025. This represents an increase of 6.4% from the prior year.

EBITDA
$1.6B
YoY+10.4%
5Y CAGR+1.7%
10Y CAGR+1.4%

The Campbell's Company's EBITDA was $1.6B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 10.4% from the prior year.

Free Cash Flow
$705.0M
YoY+5.5%
5Y CAGR-8.5%
10Y CAGR-1.6%

The Campbell's Company generated $705.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 5.5% from the prior year.

Net Income
$602.0M
YoY+6.2%
5Y CAGR-18.0%
10Y CAGR-1.0%

The Campbell's Company reported $602.0M in net income in fiscal year 2025. This represents an increase of 6.2% from the prior year.

EPS (Diluted)
$2.01
YoY+6.3%
5Y CAGR-17.8%
10Y CAGR-0.6%

The Campbell's Company earned $2.01 per diluted share (EPS) in fiscal year 2025. This represents an increase of 6.3% from the prior year.

Cash & Debt
$168.0M
YoY-79.2%
5Y CAGR-25.3%
10Y CAGR-4.4%

The Campbell's Company held $168.0M in cash against $6.1B in long-term debt as of fiscal year 2025.

Dividends Per Share
$1.54
YoY+4.1%
5Y CAGR+1.9%
10Y CAGR+2.1%

The Campbell's Company paid $1.54 per share in dividends in fiscal year 2025. This represents an increase of 4.1% from the prior year.

Shares Outstanding
298M
YoY-0.0%
5Y CAGR-0.3%
10Y CAGR-0.4%

The Campbell's Company had 298M shares outstanding in fiscal year 2025. This represents a decrease of 0.0% from the prior year.

Gross Margin
30.4%
YoY-0.4pp
5Y CAGR-4.1pp
10Y CAGR-4.0pp

The Campbell's Company's gross margin was 30.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 0.4 percentage points from the prior year.

Operating Margin
11.0%
YoY+0.6pp
5Y CAGR-1.8pp
10Y CAGR-2.1pp

The Campbell's Company's operating margin was 11.0% in fiscal year 2025, reflecting core business profitability. This is up 0.6 percentage points from the prior year.

Net Margin
5.9%
YoY-0.0pp
5Y CAGR-12.9pp
10Y CAGR-2.4pp

The Campbell's Company's net profit margin was 5.9% in fiscal year 2025, showing the share of revenue converted to profit. This is down 0.0 percentage points from the prior year.

Return on Equity
15.2%
YoY+0.5pp
5Y CAGR-43.5pp
10Y CAGR-32.0pp

The Campbell's Company's ROE was 15.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 0.5 percentage points from the prior year.

R&D Spending
$100.0M
YoY-2.0%
5Y CAGR+1.5%
10Y CAGR-1.6%

The Campbell's Company invested $100.0M in research and development in fiscal year 2025. This represents a decrease of 2.0% from the prior year.

Share Buybacks
$62.0M
YoY-7.5%
10Y CAGR-12.8%

The Campbell's Company spent $62.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 7.5% from the prior year.

Capital Expenditures
$426.0M
YoY-17.6%
5Y CAGR+7.3%
10Y CAGR+1.1%

The Campbell's Company invested $426.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 17.6% from the prior year.

CPB Income Statement

Metric Q1'26 Q1'26 Q3'25 Q2'25 Q1'26 Q2'25 Q3'25 Q2'25
Revenue $2.7B N/A $2.5B-7.8% $2.7B-3.1% $2.8B N/A $2.4B-3.5% $2.5B
Cost of Revenue $1.9B N/A $1.7B-6.4% $1.9B-2.0% $1.9B N/A $1.6B-2.6% $1.7B
Gross Profit $792.0M N/A $728.0M-11.1% $819.0M-5.5% $867.0M N/A $732.0M-5.7% $776.0M
R&D Expenses $24.0M N/A $23.0M-8.0% $25.0M-3.8% $26.0M N/A $27.0M+8.0% $25.0M
SG&A Expenses $167.0M N/A $162.0M-1.8% $165.0M-5.7% $175.0M N/A $208.0M+10.1% $189.0M
Operating Income $336.0M N/A $161.0M-50.8% $327.0M-10.9% $367.0M N/A $248.0M-21.8% $317.0M
Interest Expense $81.0M N/A $85.0M-3.4% $88.0M+1.1% $87.0M N/A $70.0M+52.2% $46.0M
Income Tax $62.0M N/A $15.0M-79.7% $74.0M+12.1% $66.0M N/A $49.0M-27.9% $68.0M
Net Income $194.0M N/A $66.0M-61.8% $173.0M-20.6% $218.0M N/A $133.0M-34.5% $203.0M
EPS (Diluted) $0.65 N/A $0.22-62.1% $0.58-19.4% $0.72 N/A $0.44-35.3% $0.68

CPB Balance Sheet

Metric Q1'26 Q1'26 Q3'25 Q2'25 Q1'26 Q2'25 Q3'25 Q2'25
Total Assets $15.2B+1.9% $14.9B+0.5% $14.8B-6.8% $15.9B-1.3% $16.1B+5.8% $15.2B-0.1% $15.2B+25.9% $12.1B
Current Assets $2.6B+14.8% $2.2B+0.3% $2.2B-30.0% $3.2B+1.4% $3.1B+43.2% $2.2B+2.4% $2.1B+3.3% $2.1B
Cash & Equivalents $168.0M+27.3% $132.0M-7.7% $143.0M-82.8% $829.0M+2.6% $808.0M+648.1% $108.0M+0.9% $107.0M-36.7% $169.0M
Inventory $1.5B+5.7% $1.4B+10.0% $1.3B+0.5% $1.3B-8.8% $1.4B+1.9% $1.4B+6.6% $1.3B+9.4% $1.2B
Accounts Receivable N/A $541.0M N/A N/A N/A $587.0M N/A N/A
Goodwill $5.0B0.0% $5.0B0.0% $5.0B+0.1% $5.0B-1.3% $5.1B-0.4% $5.1B+0.1% $5.1B+28.0% $4.0B
Total Liabilities $11.2B+2.1% $11.0B+0.3% $11.0B-8.7% $12.0B-2.2% $12.3B+7.2% $11.4B+1.0% $11.3B+37.2% $8.3B
Current Liabilities $3.1B+7.7% $2.9B+2.0% $2.8B-16.5% $3.4B-1.5% $3.5B-3.1% $3.6B+3.4% $3.5B+68.1% $2.1B
Long-Term Debt $6.1B0.0% $6.1B0.0% $6.1B-6.1% $6.5B-3.1% $6.7B+16.4% $5.8B+0.2% $5.8B+27.7% $4.5B
Total Equity $4.0B+1.4% $3.9B+0.8% $3.9B-1.1% $3.9B+1.8% $3.8B+1.3% $3.8B-3.0% $3.9B+1.7% $3.9B
Retained Earnings $4.8B+1.6% $4.7B+0.6% $4.7B-1.1% $4.7B+1.2% $4.7B+2.0% $4.6B-2.5% $4.7B+0.4% $4.7B

CPB Cash Flow Statement

Metric Q1'26 Q1'26 Q3'25 Q2'25 Q1'26 Q2'25 Q3'25 Q2'25
Operating Cash Flow $224.0M N/A N/A N/A $225.0M N/A N/A N/A
Capital Expenditures $127.0M N/A N/A N/A $110.0M N/A N/A N/A
Free Cash Flow $97.0M N/A N/A N/A $115.0M N/A N/A N/A
Investing Cash Flow -$137.0M N/A N/A N/A -$47.0M N/A N/A N/A
Financing Cash Flow -$51.0M N/A N/A N/A $523.0M N/A N/A N/A
Dividends Paid $120.0M N/A N/A N/A $116.0M N/A N/A N/A
Share Buybacks $24.0M N/A N/A N/A $54.0M N/A N/A N/A

CPB Financial Ratios

Metric Q1'26 Q1'26 Q3'25 Q2'25 Q1'26 Q2'25 Q3'25 Q2'25
Gross Margin 29.6% N/A 29.4%-1.1pp 30.5%-0.8pp 31.3% N/A 30.9%-0.7pp 31.6%
Operating Margin 12.6% N/A 6.5%-5.7pp 12.2%-1.1pp 13.2% N/A 10.5%-2.4pp 12.9%
Net Margin 7.2% N/A 2.7%-3.8pp 6.4%-1.4pp 7.9% N/A 5.6%-2.7pp 8.3%
Return on Equity 4.9% N/A 1.7%-2.7pp 4.4%-1.2pp 5.7% N/A 3.4%-1.9pp 5.3%
Return on Assets 1.3% N/A 0.4%-0.6pp 1.1%-0.3pp 1.4% N/A 0.9%-0.8pp 1.7%
Current Ratio 0.82+0.1 0.77-0.0 0.78-0.2 0.93+0.0 0.91+0.3 0.610.0 0.62-0.4 1.01
Debt-to-Equity 1.54-0.0 1.56-0.0 1.58-0.1 1.66-0.1 1.74+0.2 1.52+0.0 1.47+0.3 1.17
FCF Margin 3.6% N/A N/A N/A 4.2% N/A N/A N/A

Note: The current ratio is below 1.0 (0.82), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 44 / 100
Financial Profile 44/100
Profitability
55
Growth
47
Leverage
54
Liquidity
13
Cash Flow
34
Returns
61

Based on FY2025 annual data. Scores normalized against common benchmarks.

Altman Z-Score Distress
1.78

Bankruptcy risk indicator. Above 2.99 = safe, below 1.81 = distress.

Piotroski F-Score Strong
7/9

Financial strength trend (9 signals). 7-9 = strong, 0-3 = weak.

Earnings Quality Cash-Backed
1.88x

Operating cash flow vs net income. Above 1.0x = cash-backed earnings.

Interest Coverage Adequate
3.3x

Operating income vs interest expense. Above 5x = safe, below 2x = risky.

Similar Companies

Frequently Asked Questions

What is The Campbell's Company's annual revenue?

The Campbell's Company (CPB) reported $10.3B in total revenue for fiscal year 2025. This represents a 6.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is The Campbell's Company's revenue growing?

The Campbell's Company (CPB) revenue grew by 6.4% year-over-year, from $9.6B to $10.3B in fiscal year 2025.

Is The Campbell's Company profitable?

Yes, The Campbell's Company (CPB) reported a net income of $602.0M in fiscal year 2025, with a net profit margin of 5.9%.

What is The Campbell's Company's earnings per share (EPS)?

The Campbell's Company (CPB) reported diluted earnings per share of $2.01 for fiscal year 2025. This represents a 6.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is The Campbell's Company's EBITDA?

The Campbell's Company (CPB) had EBITDA of $1.6B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does The Campbell's Company have?

As of fiscal year 2025, The Campbell's Company (CPB) had $168.0M in cash and equivalents against $6.1B in long-term debt.

What is The Campbell's Company's gross margin?

The Campbell's Company (CPB) had a gross margin of 30.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is The Campbell's Company's operating margin?

The Campbell's Company (CPB) had an operating margin of 11.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is The Campbell's Company's net profit margin?

The Campbell's Company (CPB) had a net profit margin of 5.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does The Campbell's Company pay dividends?

Yes, The Campbell's Company (CPB) paid $1.54 per share in dividends during fiscal year 2025.

What is The Campbell's Company's return on equity (ROE)?

The Campbell's Company (CPB) has a return on equity of 15.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is The Campbell's Company's free cash flow?

The Campbell's Company (CPB) generated $705.0M in free cash flow during fiscal year 2025. This represents a 5.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is The Campbell's Company's operating cash flow?

The Campbell's Company (CPB) generated $1.1B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are The Campbell's Company's total assets?

The Campbell's Company (CPB) had $15.2B in total assets as of fiscal year 2025, including both current and long-term assets.

What are The Campbell's Company's capital expenditures?

The Campbell's Company (CPB) invested $426.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does The Campbell's Company spend on research and development?

The Campbell's Company (CPB) invested $100.0M in research and development during fiscal year 2025.

Does The Campbell's Company buy back shares?

Yes, The Campbell's Company (CPB) spent $62.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does The Campbell's Company have outstanding?

The Campbell's Company (CPB) had 298M shares outstanding as of fiscal year 2025.

What is The Campbell's Company's current ratio?

The Campbell's Company (CPB) had a current ratio of 0.82 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is The Campbell's Company's debt-to-equity ratio?

The Campbell's Company (CPB) had a debt-to-equity ratio of 1.54 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is The Campbell's Company's return on assets (ROA)?

The Campbell's Company (CPB) had a return on assets of 4.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is The Campbell's Company's Altman Z-Score?

The Campbell's Company (CPB) has an Altman Z-Score of 1.78, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress.

What is The Campbell's Company's Piotroski F-Score?

The Campbell's Company (CPB) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals.

Are The Campbell's Company's earnings high quality?

The Campbell's Company (CPB) has an earnings quality ratio of 1.88x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation.

Can The Campbell's Company cover its interest payments?

The Campbell's Company (CPB) has an interest coverage ratio of 3.3x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline.

How financially healthy is The Campbell's Company?

The Campbell's Company (CPB) scores 44 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks.